Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01948882 · ClinicalTrials.gov registry record · NA
Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
A NA study, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 660
- Enrollment target
NCT01948882 is a NA study that has completed, run by Bayer. The registered enrollment target is 660 participants.
The verdict
NCT01948882, a NA study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 660 participants
- Enrollment target
Study Summary
The Essure System is indicated for women who desire non-incisional permanent birth control (female sterilization) by occlusion of the fallopian tubes. The objective of the study is to evaluate the safety and effectiveness of the Essure System (Model ESS505) for permanent birth control in preventing pregnancy. The Essure ESS505 System includes a design modification that will be studied to determine if it provides immediate birth control, thereby removing the three months waiting period required for the commercially available Essure System Model 305 to be effective.
Interventions
- DEVICE ESS505 (BAY1454033)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 660 participants |
| Start Date | 2013-09-30 |
| Est. Completion | 2024-09-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01948882
The ClinicalTrials.gov registry entry for NCT01948882 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 660 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ESS505 (BAY1454033) is the first listed.
NCT01948882 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01948882 about?
NCT01948882 is a clinical study titled "Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women". The Essure System is indicated for women who desire non-incisional permanent birth control (female sterilization) by occlusion of the fallopian tubes. The objective of the study is to evaluate the safety and effectiveness of the Essure System (Model ESS505) for permanent birth control in preventing ...
What is the current status of trial NCT01948882?
This trial is currently completed. It is a NA study. The enrollment target is 660 participants. The study started on 2013-09-30. Estimated completion is 2024-09-12.
What interventions are being tested in trial NCT01948882?
The interventions under investigation include: ESS505 (BAY1454033) (DEVICE).
Who is sponsoring clinical trial NCT01948882?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.